Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nurix Therapeutics Inc
(NQ:
NRIX
)
25.43
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nurix Therapeutics Inc
< Previous
1
2
3
4
Next >
Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know
April 02, 2024
Via
Benzinga
Analyst Scoreboard: 7 Ratings For Nurix Therapeutics
March 11, 2024
Via
Benzinga
Decoding 4 Analyst Evaluations For Nurix Therapeutics
February 16, 2024
Via
Benzinga
Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
December 28, 2023
U.S. stock futures were mixed this morning, with the Dow Jones futures falling around 40 points on Thursday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
December 13, 2023
From
Toll Brothers, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings for Nurix Therapeutics
October 13, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Nurix Therapeutics
September 07, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 11, 2023
Via
Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
October 17, 2023
Via
Benzinga
Why Is Cancer Focused Nurix Therapeutics Stock Trading Higher Today?
September 07, 2023
Nurix Therapeutics Inc (NASDAQ: NRIX) has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc (NASDAQ: SGEN) to advance a new class of medicines called...
Via
Benzinga
Designer Brands, Calavo Growers, Couchbase And Other Big Stocks Moving Higher On Thursday
September 07, 2023
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Cuts Nurix Therapeutics Price Target By 38%, Cites Lymphoma Data
July 24, 2023
HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NASDAQ: NRIX)
Via
Benzinga
Analyst Ratings for Nurix Therapeutics
July 24, 2023
Via
Benzinga
Nurix Therapeutics's Return On Capital Employed Insights
July 14, 2023
Via
Benzinga
Analyst Ratings for Nurix Therapeutics
April 14, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 14, 2023
It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
JPMorgan, Citigroup, QuidelOrtho And Other Big Stocks Moving Higher On Friday
April 14, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Nurix Therapeutics Inc. (NASDAQ: NRIX) Highlighted for Surprising Price Action
April 13, 2023
Via
Investor Brand Network
Expert Ratings for Nurix Therapeutics
March 21, 2023
Via
Benzinga
Gilead Exercises First License Option Under Agreement With Nurix Therapeutics
March 20, 2023
Via
Benzinga
Analyst Ratings for Nurix Therapeutics
February 28, 2023
Via
Benzinga
Nurix Therapeutics's Return On Capital Employed Overview
February 14, 2023
Via
Benzinga
Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479
March 20, 2023
From
Gilead Sciences, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
March 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
The Top 5 Stocks Cathie Wood Bought and Sold This Week
October 21, 2022
Cathie Wood's flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.
Via
InvestorPlace
CSX, Veris Residential And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 21, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company
October 10, 2022
Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
October 11, 2022
Upgrades
Via
Benzinga
Why SOBR Safe Shares Surged Around 233%; Here Are 68 Biggest Movers From Yesterday
September 21, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.